{"id":"https://openalex.org/keywords/second-generation-tkis","display_name":"second-generation TKIs","description":"Second-generation TKIs are tyrosine kinase inhibitor drugs developed to treat cancers and other diseases, including chronic myeloid leukemia and EGFR-mutated lung cancer.","display_name_alternatives":[],"ids":{"openalex":"https://openalex.org/keywords/second-generation-tkis","wikidata":null},"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.7784,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.7784,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.114,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"works_count":699,"cited_by_count":12585,"works_api_url":"https://api.openalex.org/works?filter=keywords.id:keywords/second-generation-tkis","updated_date":"2026-11-16T04:05:30","created_date":"2026-09-30T00:00:00"}
